SA26 Win Ratio Analyses of Multiple Endpoints in Rare Disease Trials: A Case-Study Based on a Trial of Avaglucosidase Alfa in Late-Onset Pompe Disease (LOPD)KJ Ishak, JJ Caro,A Hamed, L Riou-Franca, N Thibault, P Shukla,KI Berger, J Diaz-Manera, MM Dimachkie, M BoentertValue in Health（2022）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
